Ensign Group (ENSG)
NASDAQHealth CareMedical - Care FacilitiesSnapshot 2026-09-04
$170.79-0.76%
Close 2026-09-04 · 1-day change
NASDAQHealth CareMedical - Care FacilitiesSnapshot 2026-09-04
QuarterlyIQ Insights · ENSG
Price, fair value, and the multiples that frame it on the same time axis. Scroll over the price chart to zoom.
Daily closes. Earnings/event dots inline.
A consensus fair price across 11 valuation methods, at three horizons. As of 2026-09-04. Estimates are diagnostics, not price targets. Short-horizon estimates are close to coin-flips, so confidence is a method-agreement read, not a prediction.
Today's peer multiple on trailing earnings, with no growth credited. This is the headline read.
Adds projected growth, so it leans optimistic by design. Read it as upside context, not a base case.
We take the 12-month fair value above and grade our own number — how the market prices this name versus what we'd justify, and where the two diverge.
At $171 ENSG trades at 24× p/e, in line with its 23× p/e peer median, and our $178 fair value agrees. We hold it with medium confidence: quality doesn't explain valuation multiples in this sub-industry, so the peer comparison is a weak guide. Not investment advice.
One valuation read at a 12-month horizon, plus how price compares to peers and the company's own history.
Score 100 = cheapest in the cohort, 0 = richest. Bars are filled left-to-right based on the peer-relative score (or PEG/self-history where shown).
Each method's implied share price per horizon. Provisional rows use a projected (historical-CAGR) growth input rather than analyst or management guidance.
| Method | Horizon | Est. price | Multiple | Per-share input | EPS source | Confidence |
|---|---|---|---|---|---|---|
| dcf fcfe | 12M | $372.90 | — | — | Hist. CAGR | high |
| dcf fcff | 12M | $377.53 | — | — | Hist. CAGR | high |
| graham number | 12M | $80.64 | — | — | TTM | high |
| Peer EV/EBITDA | 12M | $52.71 | 5.6 | 9.42 | TTM | high |
| Peer P/FCF | 12M |
A “consensus-then vs. actual-now” overlay is on the way — what our valuation estimate said on a past date versus where the price actually landed.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
A long-thesis check that carries the widest uncertainty of the three horizons.
Top 10% on quality vs scored peers
Direction of the business behind the multiple. Bands are backend reads; trailing-12-month basis.
Only weak execution quality — not the full expensive x weak x turbulent stack. Regime (Mania) does not concentrate fragility.
For similar setups historically (n=20,154): about 33% saw a 20%+ drawdown, and roughly 76% of those did not recover within the year. These are historical base rates for the cohort, not a forecast of this stock.
At today's price you pay about 78% over what the business is worth with no growth; closing that gap needs roughly 6.2 years of the forecast growth to come through. These describe the expectations embedded in the price, not a forecast of the move. Reverse-DCF base: $4.62/sh owner earnings.
Roughly priced in line with peers.
Around its own typical valuation.
Trailing four: 2025-Q2, 2025-Q3, 2026-Q1, 2026-Q2
Direction of the business behind the multiple. Bands are backend reads; trailing-12-month basis.
| $118.96 |
| 16.9 |
| 7.05 |
| TTM |
| high |
| Peer P/E | 12M | $163.08 | 23.2 | 7.03 | TTM | high |
| Peer P/S | 12M | $98.90 | 1.1 | 92.24 | TTM | high |
| PEG | 12M | $154.35 | 22.0 | 7.03 | TTM | high |
| residual income | 12M | $56.91 | — | — | TTM | high |
| Own P/E history | 12M | $171.81 | 24.4 | 7.03 | TTM | high |
| triangulated | 12M | $170.75 | 23.2 | 7.36 | Triangulated | high |
| Peer P/FCF | 3Y | $180.92 | 16.9 | 10.72 | Hist. CAGR(prov.) | medium |
| Peer P/E | 3Y | $224.96 | 23.2 | 9.70 | Analyst | medium |
| Peer P/S | 3Y | $132.96 | 1.1 | 124.00 | guidance | medium |
| PEG | 3Y | $212.91 | 22.0 | 9.70 | Analyst | medium |
| Own P/E history | 3Y | $237.00 | 24.4 | 9.70 | Analyst | medium |
| Peer P/FCF | 5Y | $239.27 | 16.9 | 14.17 | Hist. CAGR(prov.) | high |
| Peer P/E | 5Y | $259.68 | 23.2 | 11.19 | Analyst | high |
| Peer P/S | 5Y | $153.48 | 1.1 | 143.14 | guidance | high |
| PEG | 5Y | $245.78 | 22.0 | 11.19 | Analyst | high |
| Own P/E history | 5Y | $273.59 | 24.4 | 11.19 | Analyst | high |